// App-Quantinova.ai

1275 : ASXL1-Mutant Chronic Myelomonocytic Leukemia Is Associated with Increased Intratumoral Heterogeneity and Single-Cell Chromatin Co-Accessibility

Researchers

Presenter

  • Moritz Binder

Principal Investigators

  • Sandeep Potluri

  • Ryan M. Carr

  • Terra Lasho

  • Christy Finke

  • Abhishek A. Mangaonkar

  • Christopher Pin

  • Kurt Berger

  • Tamas Ordog

  • Bonnie Alver

  • Keith Robertson

  • David Marks

  • Martin Fernandez-Zapico

  • Alexandre Gaspar Maia

  • Mrinal M. Patnaik

Medical Centers

  • Division of Medical Oncology, Mayo Clinic, Rochester, MN

  • Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom

  • London Regional Transgenic and Gene Targeting Facility, Lawson Health Research Institute University of Western Ontario, London, ON, Canada

  • Center for Individualized Medicine, Mayo Clinic, Rochester, MN

  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

  • Oncology Research, Mayo Clinic, Rochester, MN

  • Mayo Clinic, Rochester, MN

Locations

  • United States

  • United Kingdom

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic myelomonocytic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved